BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33193737)

  • 1. KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
    Zhang X; Zhang J; Gao F; Fan S; Dai L; Zhang J
    Front Genet; 2020; 11():593273. PubMed ID: 33193737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma.
    Zhang J; Zhang X; Wang L; Kang C; Li N; Xiao Z; Dai L
    PeerJ; 2021; 9():e12197. PubMed ID: 34616632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma.
    Zhang X; Liu X; Zhu K; Zhang X; Li N; Sun T; Fan S; Dai L; Zhang J
    Cancer Cell Int; 2022 Dec; 22(1):393. PubMed ID: 36494696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
    Guo X; Wang Z; Zhang J; Xu Q; Hou G; Yang Y; Dong C; Liu G; Liang C; Liu L; Zhou W; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):285-292. PubMed ID: 30883648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
    Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
    Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma.
    Gao CL; Wang GW; Yang GQ; Yang H; Zhuang L
    Oncol Lett; 2018 Mar; 15(3):2815-2820. PubMed ID: 29435009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma.
    Pan Y; Zhang Y; Lu Z; Jin D; Li S
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13753-13771. PubMed ID: 37526663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
    Shang BB; Chen J; Wang ZG; Liu H
    PeerJ; 2021; 9():e12315. PubMed ID: 34754620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
    Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
    Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.
    Hu ZY; Yuan SX; Yang Y; Zhou WP; Jiang H
    J Exp Clin Cancer Res; 2014 Jul; 33(1):61. PubMed ID: 25060425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
    Zhang X; Gao F; Li N; Zhang J; Dai L; Yang H
    J Cancer; 2020; 11(11):3124-3143. PubMed ID: 32231717
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
    Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
    J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage response-related signatures characterize the immune landscape and predict the prognosis of HCC via integrating single-cell and bulk RNA-sequencing.
    Li H; Shi Y; Li Y; Wu S; Yang R; Liu Q; Sun L
    Int Immunopharmacol; 2024 Jun; 137():112475. PubMed ID: 38909498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development.
    Lu TL; Li CL; Gong YQ; Hou FT; Chen CW
    World J Gastrointest Oncol; 2023 Oct; 15(10):1717-1738. PubMed ID: 37969406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined bulk RNA and single-cell RNA analyses reveal TXNL4A as a new biomarker for hepatocellular carcinoma.
    Li Y; Zhu Q; Zhou S; Chen J; Du A; Qin C
    Front Oncol; 2023; 13():1202732. PubMed ID: 37305572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircMYH9 increases KPNA2 mRNA stability to promote hepatocellular carcinoma progression in an EIF4A3-dependent manner.
    Xia J; Wu C; Tang Y; Tang J; Zhu D; Zhang F; Xu Z; Sun D; Tan Z; Zhuo H
    Am J Cancer Res; 2022; 12(9):4361-4372. PubMed ID: 36225644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis.
    Zhang X; Kang C; Li N; Liu X; Zhang J; Gao F; Dai L
    PeerJ; 2019; 7():e6375. PubMed ID: 30755830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.